Ikarian Capital, LLC Immunic, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 914,170 shares of IMUX stock, worth $877,603. This represents 0.14% of its overall portfolio holdings.
Number of Shares
914,170
Previous 635,800
43.78%
Holding current value
$877,603
Previous $635,000
56.85%
% of portfolio
0.14%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
40.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$8.55 Million0.43% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$4.28 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.77 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$2.03 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $29.3M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...